Identifying Possible AChE Inhibitors from Drug-like Molecules via Machine Learning and Experimental Studies
- PMID: 35755364
- PMCID: PMC9219098
- DOI: 10.1021/acsomega.2c00908
Identifying Possible AChE Inhibitors from Drug-like Molecules via Machine Learning and Experimental Studies
Abstract
Acetylcholinesterase (AChE) is one of the most important drug targets for Alzheimer's disease (AD) treatment. In this work, a machine learning model was trained to rapidly and accurately screen large chemical databases for the potential inhibitors of AChE. The obtained results were then validated via in vitro enzyme assay. Moreover, atomistic simulations including molecular docking and molecular dynamics simulations were then used to understand molecular insights into the binding process of ligands to AChE. In particular, two compounds including benzyl trifluoromethyl ketone and trifluoromethylstyryl ketone were indicated as highly potent inhibitors of AChE because they established IC50 values of 0.51 and 0.33 μM, respectively. The obtained IC50 of two compounds is significantly lower than that of galantamine (2.10 μM). The predicted log(BB) suggests that the compounds may be able to traverse the blood-brain barrier. A good agreement between computational and experimental studies was observed, indicating that the hybrid approach can enhance AD therapy.
© 2022 The Authors. Published by American Chemical Society.
Conflict of interest statement
The authors declare no competing financial interest.
Figures





Similar articles
-
Searching for AChE inhibitors from natural compounds by using machine learning and atomistic simulations.J Mol Graph Model. 2022 Sep;115:108230. doi: 10.1016/j.jmgm.2022.108230. Epub 2022 May 27. J Mol Graph Model. 2022. PMID: 35661591
-
Binding interaction of acetylcholinesterase with steroidal pregnanes: insight from machine learning and atomistic simulation.J Biomol Struct Dyn. 2025 Mar 26:1-27. doi: 10.1080/07391102.2025.2480262. Online ahead of print. J Biomol Struct Dyn. 2025. PMID: 40135660
-
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.Int J Risk Saf Med. 2015;27 Suppl 1:S69-71. doi: 10.3233/JRS-150694. Int J Risk Saf Med. 2015. PMID: 26639718
-
Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.Eur J Med Chem. 2021 Apr 5;215:113224. doi: 10.1016/j.ejmech.2021.113224. Epub 2021 Feb 2. Eur J Med Chem. 2021. PMID: 33582578
-
Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).Expert Opin Ther Pat. 2017 Apr;27(4):455-476. doi: 10.1080/13543776.2017.1272571. Epub 2017 Jan 17. Expert Opin Ther Pat. 2017. PMID: 27967267 Review.
Cited by
-
Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs.Molecules. 2023 Jan 30;28(3):1324. doi: 10.3390/molecules28031324. Molecules. 2023. PMID: 36770990 Free PMC article. Review.
-
Discovery of novel theophylline derivatives bearing tetrazole scaffold for the treatment of Alzheimer's disease.RSC Adv. 2025 Mar 4;15(9):6994-7003. doi: 10.1039/d5ra00488h. eCollection 2025 Feb 26. RSC Adv. 2025. PMID: 40041377 Free PMC article.
-
Alchemical approach performance in calculating the ligand-binding free energy.RSC Adv. 2024 May 8;14(21):14875-14885. doi: 10.1039/d4ra00692e. eCollection 2024 May 2. RSC Adv. 2024. PMID: 38720975 Free PMC article.
-
Probing the Reactions of Thiourea (CH4N2S) with Metals (X = Au, Hf, Hg, Ir, Os, W, Pt, and Re) Anchored on Fullerene Surfaces (C59X).ACS Omega. 2022 Sep 19;7(39):35118-35135. doi: 10.1021/acsomega.2c04044. eCollection 2022 Oct 4. ACS Omega. 2022. Retraction in: ACS Omega. 2024 Nov 12;9(47):47373. doi: 10.1021/acsomega.4c09370. PMID: 36211036 Free PMC article. Retracted.
-
Validation of Acetylcholinesterase Inhibition Machine Learning Models for Multiple Species.Chem Res Toxicol. 2023 Feb 20;36(2):188-201. doi: 10.1021/acs.chemrestox.2c00283. Epub 2023 Feb 3. Chem Res Toxicol. 2023. PMID: 36737043 Free PMC article.
References
-
- 2018 Alzheimer’s disease facts and figures. Alzheimer’s Dementia 2018, 14, 367.10.1016/j.jalz.2018.02.001. - DOI
-
- Nasica-Labouze J.; Nguyen P. H.; Sterpone F.; Berthoumieu O.; Buchete N.-V.; Coté S.; De Simone A.; Doig A. J.; Faller P.; Garcia A.; Laio A.; Li M. S.; Melchionna S.; Mousseau N.; Mu Y.; Paravastu A.; Pasquali S.; Rosenman D. J.; Strodel B.; Tarus B.; Viles J. H.; Zhang T.; Wang C.; Derreumaux P. Amyloid β Protein and Alzheimer’s Disease: When Computer Simulations Complement Experimental Studies. Chem. Rev. 2015, 115, 3518–3563. 10.1021/cr500638n. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources